272 related articles for article (PubMed ID: 32546231)
21. Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome.
Bednarska S; Fryczak J; Siejka A
Cytokine; 2020 Oct; 134():155188. PubMed ID: 32673996
[TBL] [Abstract][Full Text] [Related]
22. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
[TBL] [Abstract][Full Text] [Related]
23. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
[TBL] [Abstract][Full Text] [Related]
24. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.
Dostálová I; Kaválková P; Haluzíková D; Lacinová Z; Mráz M; Papezová H; Haluzík M
J Clin Endocrinol Metab; 2008 Sep; 93(9):3627-32. PubMed ID: 18559909
[TBL] [Abstract][Full Text] [Related]
25. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
26. Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation.
von Berghes C; Brabant G; Biebermann H; Krude H; Wiegand S
Pediatr Diabetes; 2011 May; 12(3 Pt 2):242-9. PubMed ID: 21518412
[TBL] [Abstract][Full Text] [Related]
27. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.
Ko BJ; Kim SM; Park KH; Park HS; Mantzoros CS
Int J Obes (Lond); 2014 Dec; 38(12):1497-502. PubMed ID: 24638201
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Metabolic Syndrome and Impaired Glucose Metabolism among 10- to 17-Year-Old Overweight and Obese Lithuanian Children and Adolescents.
Smetanina N; Valickas R; Vitkauskiene A; Albertsson-Wikland K; Verkauskienė R
Obes Facts; 2021; 14(3):271-282. PubMed ID: 33951670
[TBL] [Abstract][Full Text] [Related]
29. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study.
Li G; Yin J; Fu J; Li L; Grant SFA; Li C; Li M; Mi J; Li M; Gao S
Diabetes Metab; 2017 Jun; 43(3):253-260. PubMed ID: 28139438
[TBL] [Abstract][Full Text] [Related]
30. Elevated 1-hour post-load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile.
Serbis A; Giapros V; Challa A; Chaliasos N; Siomou E
Clin Endocrinol (Oxf); 2018 Dec; 89(6):757-764. PubMed ID: 30229983
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between insulin resistance, serum VCAM-1, FGF19, IGF-1 and colorectal polyps].
Qin M; Wang HP; Song B; Sun YL; Wang DY; Chen M; Shi HX; Zhang H; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):553-562. PubMed ID: 34034475
[No Abstract] [Full Text] [Related]
32. Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children.
Zhang Y; Li G; Xiao F; Wang B; Li J; Jia X; Sun Y; Chen H
BMC Pediatr; 2023 Mar; 23(1):120. PubMed ID: 36927328
[TBL] [Abstract][Full Text] [Related]
33. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
34. Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents.
Bisgaard A; Sørensen K; Johannsen TH; Helge JW; Andersson AM; Juul A
Int J Pediatr Endocrinol; 2014; 2014(1):7. PubMed ID: 24883065
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance.
Wu S; Gao H; Ma Y; Fu L; Zhang C; Luo X
Pediatr Diabetes; 2016 Feb; 17(1):53-60. PubMed ID: 25413012
[TBL] [Abstract][Full Text] [Related]
36. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
[TBL] [Abstract][Full Text] [Related]
37. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents.
Wojcik M; Janus D; Dolezal-Oltarzewska K; Kalicka-Kasperczyk A; Poplawska K; Drozdz D; Sztefko K; Starzyk JB
J Pediatr Endocrinol Metab; 2012; 25(11-12):1089-93. PubMed ID: 23329754
[TBL] [Abstract][Full Text] [Related]
38. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis.
Takebe N; Hasegawa Y; Matsushita Y; Chiba H; Onodera K; Kinno H; Oda T; Nagasawa K; Segawa T; Takahashi Y; Okada K; Ishigaki Y
Medicine (Baltimore); 2023 Sep; 102(35):e34797. PubMed ID: 37657012
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
40. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
